NCT00243347View on ClinicalTrials.gov

The Effects of AZD2171 in Patients With Non-Small Cell Lung Cancer or Head & Neck Cancer

PHASE1CompletedINTERVENTIONAL

Enrollment

19

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

May 31, 2008

Study Completion Date

July 31, 2009

Conditions

CarcinomaNon-Small-Cell Lung CarcinomaHead and Neck Neoplasms

Interventions

DRUG

AZD2171

oral tablet

Trial Locations (2)

Unknown

Research Site, Houston

Research Site, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY